These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21994354)

  • 1. A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults.
    Harro C; Sack D; Bourgeois AL; Walker R; DeNearing B; Feller A; Chakraborty S; Buchwaldt C; Darsley MJ
    Clin Vaccine Immunol; 2011 Dec; 18(12):2118-27. PubMed ID: 21994354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of a live attenuated enterotoxigenic Escherichia coli combination vaccine expressing six colonization factors and heat-labile toxin subunit B.
    Turner AK; Stephens JC; Beavis JC; Greenwood J; Gewert C; Randall R; Freeman D; Darsley MJ
    Clin Vaccine Immunol; 2011 Dec; 18(12):2128-35. PubMed ID: 21994355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
    Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
    Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.
    Lundgren A; Bourgeois L; Carlin N; Clements J; Gustafsson B; Hartford M; Holmgren J; Petzold M; Walker R; Svennerholm AM
    Vaccine; 2014 Dec; 32(52):7077-84. PubMed ID: 25444830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
    Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults.
    McKenzie R; Bourgeois AL; Engstrom F; Hall E; Chang HS; Gomes JG; Kyle JL; Cassels F; Turner AK; Randall R; Darsley M; Lee C; Bedford P; Shimko J; Sack DA
    Infect Immun; 2006 Feb; 74(2):994-1000. PubMed ID: 16428745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses.
    Akhtar M; Chowdhury MI; Bhuiyan TR; Kaim J; Ahmed T; Rafique TA; Khan A; Rahman SIA; Khanam F; Begum YA; Sharif MZ; Islam LN; Carlin N; Maier N; Fix A; Wierzba TF; Walker RI; Bourgeois AL; Svennerholm AM; Qadri F; Lundgren A
    Vaccine; 2019 Sep; 37(37):5645-5656. PubMed ID: 30473185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
    Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
    Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease.
    Darsley MJ; Chakraborty S; DeNearing B; Sack DA; Feller A; Buchwaldt C; Bourgeois AL; Walker R; Harro CD
    Clin Vaccine Immunol; 2012 Dec; 19(12):1921-31. PubMed ID: 23035175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial.
    Sukwa N; Mubanga C; Hatyoka LM; Chilyabanyama ON; Chibuye M; Mundia S; Munyinda M; Kamuti E; Siyambango M; Badiozzaman S; Bosomprah S; Carlin N; Kaim J; Sjöstrand B; Simuyandi M; Chilengi R; Svennerholm AM
    Vaccine; 2023 Nov; 41(46):6884-6894. PubMed ID: 37838479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs.
    Fairbrother JM; Nadeau É; Bélanger L; Tremblay CL; Tremblay D; Brunelle M; Wolf R; Hellmann K; Hidalgo Á
    Vaccine; 2017 Jan; 35(2):353-360. PubMed ID: 27916413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of escalating dosages of a single oral administration of peru-15 pCTB, a candidate live, attenuated vaccine against enterotoxigenic Escherichia coli and Vibrio cholerae.
    Chen WH; Garza J; Choquette M; Hawkins J; Hoeper A; Bernstein DI; Cohen MB
    Clin Vaccine Immunol; 2015 Jan; 22(1):129-35. PubMed ID: 25410205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
    Harro C; Louis Bourgeois A; Sack D; Walker R; DeNearing B; Brubaker J; Maier N; Fix A; Dally L; Chakraborty S; Clements JD; Saunders I; Darsley MJ
    Vaccine; 2019 Mar; 37(14):1978-1986. PubMed ID: 30797634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral immunization of a live attenuated Escherichia coli strain expressing a holotoxin-structured adhesin-toxoid fusion (1FaeG-FedF-LTA₂:5LTB) protected young pigs against enterotoxigenic E. coli (ETEC) infection.
    Ruan X; Zhang W
    Vaccine; 2013 Mar; 31(11):1458-63. PubMed ID: 23375979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiepitope fusion antigen induces broadly protective antibodies that prevent adherence of Escherichia coli strains expressing colonization factor antigen I (CFA/I), CFA/II, and CFA/IV.
    Ruan X; Knudsen DE; Wollenberg KM; Sack DA; Zhang W
    Clin Vaccine Immunol; 2014 Feb; 21(2):243-9. PubMed ID: 24351757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407.
    Chakraborty S; Harro C; DeNearing B; Ram M; Feller A; Cage A; Bauers N; Bourgeois AL; Walker R; Sack DA
    Clin Vaccine Immunol; 2016 Jan; 23(1):55-64. PubMed ID: 26581889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial.
    Qadri F; Akhtar M; Bhuiyan TR; Chowdhury MI; Ahmed T; Rafique TA; Khan A; Rahman SIA; Khanam F; Lundgren A; Wiklund G; Kaim J; Löfstrand M; Carlin N; Bourgeois AL; Maier N; Fix A; Wierzba T; Walker RI; Svennerholm AM
    Lancet Infect Dis; 2020 Feb; 20(2):208-219. PubMed ID: 31757774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC.
    McKenzie R; Darsley M; Thomas N; Randall R; Carpenter C; Forbes E; Finucane M; Sack RB; Hall E; Bourgeois AL
    Vaccine; 2008 Aug; 26(36):4731-9. PubMed ID: 18602960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli.
    El-Kamary SS; Cohen MB; Bourgeois AL; Van De Verg L; Bauers N; Reymann M; Pasetti MF; Chen WH
    Clin Vaccine Immunol; 2013 Nov; 20(11):1764-70. PubMed ID: 24049109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-based vaccine candidate MecVax broadly protects against enterotoxigenic
    Upadhyay I; Parvej SMD; Shen Y; Li S; Lauder KL; Zhang C; Zhang W
    Infect Immun; 2023 Nov; 91(11):e0027223. PubMed ID: 37874163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.